Vasileios G. Peponis
National and Kapodistrian University of Athens
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Vasileios G. Peponis.
Clinical Ophthalmology | 2010
Vasileios G. Peponis; Spyridon E. Chalkiadakis; Stefanos Bonovas; Nikolaos M. Sitaras
Objective: Age-related macular degeneration (AMD) is the leading cause of blindness in western societies. Statins comprise a class of pharmacological agents that reduce plasma cholesterol levels, and have been shown to prevent progression of atherosclerosis and reduce cardiovascular mortality. The relationship between these medications and AMD has been evaluated in several recent studies. Herein, we examine the current evidence for an association between statin use and risk of AMD. Methods: Literature database search (Medline, Scopus, and Science Citation Index Expanded) for articles published up to March 2010, using particular search terms. Results: From the current evidence available, it is not safe to conclude upon the assumption of a protective effect of statins against age-related maculopathy and AMD. Conclusion: There is a need for large scale prospective studies with a long follow-up period and accurate assessment of AMD to further explore this matter.
Case Reports in Ophthalmology | 2012
Vasileios G. Peponis; Irini P. Chatziralli; Efstratios Parikakis; Niki Chaira; Michail Katzakis; Panagiotis G. Mitropoulos
Epstein-Barr virus (EBV) is a DNA virus that mainly causes infectious mononucleosis. Ocular manifestations are rare and typically mild. Only a few cases of EBV involving the retina or the optic nerve have been reported. Herein, we report the case of a 67-year-old man with bilateral chorioretinitis and optic neuritis due to EBV. The patient had no previous ocular history and presented with decreased vision in both eyes. His past medical history included EBV encephalopathy, which was confirmed serologically, a few months before. Ophthalmological examination revealed bilateral chorioretinitis and optic neuritis, confirmed by fluorescein angiography as well as electrophysiological tests (visual evoked potentials and electroretinogram). It is very important to include EBV in the differential diagnosis of chorioretinal atrophic lesions. Clinicians should be aware of ocular manifestations of EBV, in order to suggest ophthalmological examination and start treatment promptly before irreversible damage to the optic nerve or retina occurs.
Case Reports in Ophthalmology | 2013
Efstratios Parikakis; Irini P. Chatziralli; Vasileios G. Peponis; Georgios David; Spyridon E. Chalkiadakis; Panagiotis G. Mitropoulos
Our purpose was to examine the long-term efficacy of toric intraocular lens (IOL) implantation in cataract patients with high astigmatism due to corneal ectasia, who underwent phacoemulsification cataract surgery. Five eyes of 3 cataract patients with topographically stable keratoconus or pellucid macular degeneration (PMD), in which phacoemulsification with toric IOL implantation was used to correct high astigmatism, are reported. Objective and subjective refraction, visual acuity measurement and corneal topography were performed in all cases before and after cataract surgery. In all cases, there was a significant improvement in visual acuity, as well as refraction, which remained stable over time. Specifically, in subjective refraction, all patients achieved visual acuity from 7/10 to 9/10 with up to -2.50 cyl. Corneal topography also remained stable. Postoperative follow-up was 18-28 months. Cataract surgery with toric IOL implantation seems to be safe and effective in correcting astigmatism and improving visual function in cataract patients with topographically stable keratoconus or PMD.
Seminars in Ophthalmology | 2014
Irini P. Chatziralli; Adil Jaulim; Vasileios G. Peponis; Panagiotis G. Mitropoulos; Marilita M. Moschos
Abstract Background: Retinal vein occlusion is the second most common retinal vascular disorder after diabetic retinopathy and is considered to be an important cause of visual loss. In this review, our purpose is to update the literature about the treatment alternatives for branch retinal vein occlusion. Methods: Eligible papers were identified by a comprehensive literature search of PubMed, using the terms “branch retinal vein occlusion,” “therapy,” “intervention,” “treatment,” “vitrectomy,” “sheathotomy,” “laser,” “anti-VEGF,” “pegaptanib,” “bevacizumab,” “ranibizumab,” “triamcinolone,” “dexamethasone,” “corticosteroids,” “non-steroids,” “diclofenac,” “hemodilution,” “fibrinolysis,” “tPA,” and “BRVO.” Additional papers were also selected from reference lists of papers identified by the electronic database search. Results: Treatment modalities were analyzed. Conclusions: There are several treatment modalities for branch retinal vein occlusion and specifically for its complications, such as macular edema, vitreous hemorrhage, retinal neovascularization, and retinal detachment, including anti-aggregative therapy and fibrinolysis, isovolemic hemodilution, vitrectomy with or without sheathotomy, peripheral scatter and macular grid retinal laser therapy, non-steroid agents, intravitreal steroids, and intravitreal anti-vascular endothelial growth factors (anti-VEGFs).
Ophthalmic Genetics | 2014
Nikolaos S. Kokolakis; Maria Gazouli; Irini P. Chatziralli; Chryssanthi Koutsandrea; Zisis Gatzioufas; Vasileios G. Peponis; Christos Kalogeropoulos; Nicholas P. Anagnou; Dimitrios Miltsakakis; Marilita M. Moschos
Abstract Background: In this study, we conducted the genotyping of D326Y in COL4A3 and M1327V, as well as F1644F in COL4A4 polymorphisms, in a case–control sample panel of Greek origin population. Materials and Methods: A case–control panel, with 45 keratoconus (KC) patients and 78 healthy controls, were surveyed. DNA from each individual was tested for the D326Y in COL4A3 and M1327V, as well as F1644F in COL4A4 polymorphisms by direct sequencing. Results: When analyzing the Hardy-Weinberg equilibrium, we observed no significant deviation from expected numbers in both KC patients and controls. The genotype frequencies in the polymorphisms tested were not found to be significantly associated with KC development risk. The M1327V AA and F1644F TT genotypes were significantly over-represented in healthy individuals. Conclusions: We could hypothesize that mutations in COL4A3 and COL4A4 genes are not involved in KC risk in Greek population. Nevertheless, the M1327V AA and F1644F TT genotypes were significantly over-represented in healthy individuals, suggesting a protective role of these genotypes in KC development risk in our population.
Clinical Ophthalmology | 2012
Vasileios G. Peponis; Spyridon E. Chalkiadakis; Michail Katzakis; Efstratios Parikakis
The purpose of our systematic review is to document the adverse events that follow phacoemulsification in eyes with trabeculectomy due to glaucoma and to determine whether phacoemulsification jeopardizes the survival of the trabeculectomy. Our research was based on English- and non-English-language articles obtained using the Medline, Embase, Web of Science and Scopus databases. Additional studies were identified by searching bibliographies in the British Library and abstracts presented at the Association for Research in Vision and Ophthalmology annual meetings. Search terms included randomized controlled trial, controlled clinical trial, random allocation, double-blind method, matched studies and trabeculectomy failure, glaucoma-filtering operation failure, bleb failure and cataract surgery or phacoemulsification. Only prospective or retrospective matched studies testing the survival of a trabeculectomy alone versus clear corneal phacoemulsification after a trabeculectomy in patients with glaucoma were included. Data were independently extracted by two authors using predefined data fields. PubMed yielded 152 results, Scopus 235, Embase 222, and Web of Science (science citation index) 216. We read the abstracts of all the trials, and after reading the full text of 31 studies, we decided that 13 studies should be comprehensively evaluated. Current evidence does not allow us to draw safe conclusions on the scientific question so far.
Journal of Cataract and Refractive Surgery | 2011
Vasileios G. Peponis; Spyridon E. Chalkiadakis; Spyridon D. Nikas; Nikolaos Makris; Ioannis Ladas; Dimitrios Karagiannis
UNLABELLED We describe the case of a 54-year-old white man who experienced bilateral central serous chorioretinopathy following laser in situ keratomileusis for myopia. Postoperatively, the uncorrected visual acuity was 20/20 in both eyes. One month later, the patient reported a decrease of vision in both eyes. Dilated fundus examination, fluorescein and indocyanine green angiography, and optical coherence tomography showed bilateral central serous chorioretinopathy. Photodynamic therapy was performed twice, and visual acuity improved. FINANCIAL DISCLOSURE No author has a financial or proprietary interest in any material or method mentioned.
Ocular Immunology and Inflammation | 2015
Panagiotis G. Mitropoulos; Irini P. Chatziralli; Vasileios G. Peponis; Evangelos Drakos; Efstratios Parikakis
Abstract Purpose: The purpose of our study was to evaluate the potential efficacy and safety of intravitreal ranibizumab in patients with pseudophakic cystoid macular edema (CME). Methods: This retrospective study comprised 7 eyes with CME treated with intravitreal ranibizumab. Patients were examined at 1 week and 1 month after injection and monthly thereafter. Main outcome measures included changes in best-corrected visual acuity (BCVA) and central retinal thickness (CRT). Safety was assessed by ophthalmic examination and report of systemic adverse effects. Results: There was a statistically significant difference on BCVA (p < 0.001) and CRT (p < 0.001) before and after the ranibizumab injection. One injection appeared to be sufficient for the resolution of CME, while recurrence was observed in 1 patient, in a long-term follow-up. No observable ocular or systemic side effects were found. Conclusions: Intravitreal ranibizumab seems to be effective and safe for the treatment of pseudophakic CME, demonstrating a statistically significant difference in BCVA as well as CRT.
Case Reports in Ophthalmology | 2014
Efstratios Parikakis; Irini P. Chatziralli; Vasileios G. Peponis; Dimitrios Karagiannis; Aimilianos A. Stratos; Vasileia A. Tsiotra; Panagiotis G. Mitropoulos
Purpose: To report a case of spontaneous resolution of a long-standing serous macular detachment associated with an optic disc pit, leading to significant visual improvement. Case Presentation: A 63-year-old female presented with a 6-month history of blurred vision and micropsia in her left eye. Her best-corrected visual acuity was 6/24 in the left eye, and fundoscopy revealed serous macular detachment associated with optic disc pit, which was confirmed by optical coherence tomography (OCT). The patient was offered vitrectomy as a treatment alternative, but she preferred to be reviewed conservatively. Three years after initial presentation, neither macular detachment nor subretinal fluid was evident in OCT, while the inner segment/outer segment (IS/OS) junction line was intact. Her visual acuity was improved from 6/24 to 6/12 in her left eye, remaining stable at the 6-month follow-up after resolution. Conclusion: We present a case of spontaneous resolution of a long-standing macular detachment associated with an optic disc pit with significant visual improvement, postulating that the integrity of the IS/OS junction line may be a prognostic factor for final visual acuity and suggesting OCT as an indicator of visual prognosis and the probable necessity of a surgical management.
Case Reports in Ophthalmology | 2011
Vasileios G. Peponis; Spyridon E. Chalkiadakis; Efstratios Parikakis; Panagiotis G. Mitropoulos
We report a female patient who developed chronic endophthalmitis after an uneventful cataract surgery. Cultures of aqueous humor and a vitreous sample showed positivity for Actinomyces meyeri. Intense anterior segment inflammation and a less evident impairment of the patient’s posterior segment led us to treat her vigorously with pars plana vitrectomy combined with intraocular and topical antibiotics. The patient achieved a good recovery of vision without the need to remove the intraocular lens and to add systemic drugs. To the best of our knowledge, this is the first reported case of an intraocular infection caused by A. meyeri after small-incision clear corneal phacoemulsification.